Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 228

1.

Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Rader EP, Turk R, Willer T, Beltrán D, Inamori K, Peterson TA, Engle J, Prouty S, Matsumura K, Saito F, Anderson ME, Campbell KP.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10992-7. doi: 10.1073/pnas.1605265113. Epub 2016 Sep 13.

2.

Dystroglycan Suppresses Notch to Regulate Stem Cell Niche Structure and Function in the Developing Postnatal Subventricular Zone.

McClenahan FK, Sharma H, Shan X, Eyermann C, Colognato H.

Dev Cell. 2016 Sep 12;38(5):548-66. doi: 10.1016/j.devcel.2016.07.017. Epub 2016 Aug 25.

3.

The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy.

Bozzi M, Cassetta A, Covaceuszach S, Bigotti MG, Bannister S, Hübner W, Sciandra F, Lamba D, Brancaccio A.

PLoS One. 2015 May 1;10(5):e0124277. doi: 10.1371/journal.pone.0124277. eCollection 2015.

4.

Sustained down-regulation of β-dystroglycan and associated dysfunctions of astrocytic endfeet in epileptic cerebral cortex.

Gondo A, Shinotsuka T, Morita A, Abe Y, Yasui M, Nuriya M.

J Biol Chem. 2014 Oct 31;289(44):30279-88. doi: 10.1074/jbc.M114.588384. Epub 2014 Sep 16.

5.

Postnatal development of the molecular complex underlying astrocyte polarization.

Lunde LK, Camassa LM, Hoddevik EH, Khan FH, Ottersen OP, Boldt HB, Amiry-Moghaddam M.

Brain Struct Funct. 2015 Jul;220(4):2087-101. doi: 10.1007/s00429-014-0775-z. Epub 2014 Apr 29.

6.

Glycosylation of α-dystroglycan: O-mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases.

Tran DT, Lim JM, Liu M, Stalnaker SH, Wells L, Ten Hagen KG, Live D.

J Biol Chem. 2012 Jun 15;287(25):20967-74. doi: 10.1074/jbc.M112.370387. Epub 2012 May 1.

7.

Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet.

Noell S, Wolburg-Buchholz K, Mack AF, Beedle AM, Satz JS, Campbell KP, Wolburg H, Fallier-Becker P.

Eur J Neurosci. 2011 Jun;33(12):2179-86. doi: 10.1111/j.1460-9568.2011.07688.x. Epub 2011 Apr 19.

8.

A dystroglycan mutation associated with limb-girdle muscular dystrophy.

Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltrán-Valero de Bernabé D, Gündeşli H, Willer T, Satz JS, Crawford RW, Burden SJ, Kunz S, Oldstone MB, Accardi A, Talim B, Muntoni F, Topaloğlu H, Dinçer P, Campbell KP.

N Engl J Med. 2011 Mar 10;364(10):939-46. doi: 10.1056/NEJMoa1006939.

9.

Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.

Jarad G, Pippin JW, Shankland SJ, Kreidberg JA, Miner JH.

Am J Physiol Renal Physiol. 2011 Mar;300(3):F811-20. doi: 10.1152/ajprenal.00725.2010. Epub 2011 Jan 5.

10.

Functional glycosylation of dystroglycan is crucial for thymocyte development in the mouse.

Liou LY, Walsh KB, Vartanian AR, Beltran-Valero de Bernabe D, Welch M, Campbell KP, Oldstone MB, Kunz S.

PLoS One. 2010 Mar 29;5(3):e9915. doi: 10.1371/journal.pone.0009915.

11.
12.

Modulation of cell spreading and cell-substrate adhesion dynamics by dystroglycan.

Thompson O, Moore CJ, Hussain SA, Kleino I, Peckham M, Hohenester E, Ayscough KR, Saksela K, Winder SJ.

J Cell Sci. 2010 Jan 1;123(Pt 1):118-27. doi: 10.1242/jcs.047902.

13.

Visual impairment in the absence of dystroglycan.

Satz JS, Philp AR, Nguyen H, Kusano H, Lee J, Turk R, Riker MJ, Hernández J, Weiss RM, Anderson MG, Mullins RF, Moore SA, Stone EM, Campbell KP.

J Neurosci. 2009 Oct 21;29(42):13136-46. doi: 10.1523/JNEUROSCI.0474-09.2009. Erratum in: J Neurosci. 2010 Feb 3;30(5):1983. J Neurosci. 2010 Jan 13;30(2):797.

14.

Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter.

Rettino A, Rafanelli F, Genovese G, Goracci M, Cifarelli RA, Cittadini A, Sgambato A.

Am J Physiol Cell Physiol. 2009 Nov;297(5):C1113-23. doi: 10.1152/ajpcell.00189.2009. Epub 2009 Aug 5.

15.

Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism for podocyte effacement?

Vogtländer NP, Visch HJ, Bakker MA, Berden JH, van der Vlag J.

PLoS One. 2009 Jun 19;4(6):e5979. doi: 10.1371/journal.pone.0005979.

16.

Dynamic regulation of alpha-dystroglycan in mouse placenta.

Santhanakrishnan M, Ray K, Oppenheimer K, Bonney EA.

Placenta. 2008 Nov;29(11):932-6. doi: 10.1016/j.placenta.2008.08.021. Epub 2008 Oct 19.

17.

Nuclear and nuclear envelope localization of dystrophin Dp71 and dystrophin-associated proteins (DAPs) in the C2C12 muscle cells: DAPs nuclear localization is modulated during myogenesis.

González-Ramírez R, Morales-Lázaro SL, Tapia-Ramírez V, Mornet D, Cisneros B.

J Cell Biochem. 2008 Oct 15;105(3):735-45. doi: 10.1002/jcb.21870.

PMID:
18680104
18.

Alpha-dystroglycan is involved in positive selection of thymocytes by participating in immunological synapse formation.

Gong Y, Zhang R, Zhang J, Xu L, Zhang F, Xu W, Wang Y, Chu Y, Xiong S.

FASEB J. 2008 May;22(5):1426-39. doi: 10.1096/fj.07-9264com. Epub 2008 Jan 2.

PMID:
18171694
19.

The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.

Milner R, Hung S, Wang X, Spatz M, del Zoppo GJ.

J Cereb Blood Flow Metab. 2008 Apr;28(4):812-23. Epub 2007 Nov 21.

20.

Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.

Weir ML, Oppizzi ML, Henry MD, Onishi A, Campbell KP, Bissell MJ, Muschler JL.

J Cell Sci. 2006 Oct 1;119(Pt 19):4047-58. Epub 2006 Sep 12.

Supplemental Content

Support Center